GNA Biosolutions GmbH

📍 Munich, Germany🗓 Founded 2010👥 23 employees💰 Last funded Jan 2020
Biotechnology Research🌐 gna-bio.com
Website LinkedIn
GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary technology, Pulse Controlled Amplification (PCA), offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. PCA assays are being developed for a number of therapeutic areas, including infectious diseases and biothreats. Nucleic acid amplification is a fundamental process in molecular biology, with a multitude of applications. In collaboration with our partners around the world, our PCA technology is taking molecular testing to places it’s never been able to go before. Our vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere. For more information, please visit www.gna-bio.com
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Germany
1
Frequently asked questions
Who invested in GNA Biosolutions GmbH?
GNA Biosolutions GmbH has 2 investors on record on gritt.io and 1 late-stage investors.
When did GNA Biosolutions GmbH last raise funding?
The most recent investment in GNA Biosolutions GmbH recorded on gritt.io was in January 2020.
When was GNA Biosolutions GmbH founded?
GNA Biosolutions GmbH was founded in 2010.
What industry is GNA Biosolutions GmbH in?
GNA Biosolutions GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GNA Biosolutions GmbH based?
GNA Biosolutions GmbH is headquartered in Munich, Germany.